1-11 of 11
Crystal L. Mackall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Clinical Trials & Observations
Mark P. Hamilton, Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani, Zachary Ehlinger, Shriya Syal, Zinaida Good, Brian Sworder, Joseph Schroers-Martin, Ying Lu, Lori Muffly, Robert S. Negrin, Sally Arai, Robert Lowsky, Everett Meyer, Andrew R. Rezvani, Judith Shizuru, Wen-Kai Weng, Parveen Shiraz, Surbhi Sidana, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, Bita Sahaf, David M. Kurtz, Crystal L. Mackall, Robert Tibshirani, Ash A. Alizadeh, Matthew J. Frank, David B. Miklos
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3314–3326.
https://doi.org/10.1182/bloodadvances.2024012637
Published: 2024
Includes: Supplemental data
Journal Articles

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

Clinical Trials & Observations
Kevin O. McNerney, Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J. Chen, Christina Baggott, Snehit Prabhu, Holly L. Pacenta, Christine Philips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Michael Verneris, Doug Myers, Nicole A. Karras, Patrick Brown, Challice L. Bonifant, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Susanne H. C. Baumeister, Vanessa A. Fabrizio, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2758–2771.
https://doi.org/10.1182/bloodadvances.2022008893
Published: 2023
Includes: Supplemental data
Journal Articles

Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

Heather E. Stefanski, Anne Eaton, Christina Baggott, Jenna Rossoff, Michael R. Verneris, Snehit Prabhu, Holly L. Pacenta, Christine L. Phillips, Julie-An Talano, Amy Moskop, Steven P. Margossian, Gary Douglas Myers, Nicole A. Karras, Patrick A. Brown, Muna Qayed, Michelle Hermiston, Prakash Satwani, M. Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Journal: Blood Advances
Blood Adv (2023) 7 (4): 541–548.
https://doi.org/10.1182/bloodadvances.2022007246
Published: 2023
Includes: Supplemental data
Journal Articles

The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes

Clinical Trials & Observations
Aiman J. Faruqi, John A. Ligon, Paul Borgman, Seth M. Steinberg, Toni Foley, Lauren Little, Crystal L. Mackall, Daniel W. Lee, Terry J. Fry, Haneen Shalabi, Jennifer Brudno, Bonnie Yates, Lekha Mikkilineni, James Kochenderfer, Nirali N. Shah
Journal: Blood Advances
Blood Adv (2022) 6 (23): 6040–6050.
https://doi.org/10.1182/bloodadvances.2022007676
Published: 2022
Includes: Supplemental data
Journal Articles

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

Amy Moskop, Lauren Pommert, Christina Baggott, Snehit Prabhu, Holly L. Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Steve P. Margossian, Michael R. Verneris, G. Doug Myers, Nicole A. Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Erin M. Guest, Erin H. Breese, Liora M. Schultz
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4251–4255.
https://doi.org/10.1182/bloodadvances.2021006393
Published: 2022
Journal Articles

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Clinical Trials & Observations
Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Steven P. Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole A. Karras, Patrick A. Brown, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz, Kevin J. Curran
Journal: Blood Advances
Blood Adv (2022) 6 (7): 1961–1968.
https://doi.org/10.1182/bloodadvances.2021006418
Published: 2022
Includes: Supplemental data
Journal Articles

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

Clinical Trials & Observations
Vanessa A. Fabrizio, Christine L. Phillips, Adam Lane, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Steven P. Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole A. Karras, Patrick A. Brown, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Journal: Blood Advances
Blood Adv (2022) 6 (2): 600–610.
https://doi.org/10.1182/bloodadvances.2021005564
Published: 2022
Journal Articles

Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days

Clinical Trials & Observations
Lekha Mikkilineni, Bonnie Yates, Seth M. Steinberg, Shilpa A. Shahani, John C. Molina, Tara Palmore, Daniel W. Lee, Rosandra N. Kaplan, Crystal L. Mackall, Terry J. Fry, Juan Gea-Banacloche, Theresa Jerussi, Veronique Nussenblatt, James N. Kochenderfer, Nirali N. Shah
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5312–5322.
https://doi.org/10.1182/bloodadvances.2021004896
Published: 2021
Includes: Supplemental data
Journal Articles

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Clinical Trials & Observations
John H. Baird, David J. Epstein, John S. Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig, Gursharan K. Claire, Matthew J. Frank, Lori Muffly, Parveen Shiraz, Everett Meyer, Sally Arai, Janice (Wes) Brown, Laura Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Wen-Kai Weng, Theresa Latchford, Bita Sahaf, Crystal L. Mackall, David B. Miklos, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2021) 5 (1): 143–155.
https://doi.org/10.1182/bloodadvances.2020002732
Published: 2021
Includes: Supplemental data
Journal Articles

Pharmacologic control of CAR-T cell function using dasatinib

Evan W. Weber, Rachel C. Lynn, Elena Sotillo, John Lattin, Peng Xu, Crystal L. Mackall
Journal: Blood Advances
Blood Adv (2019) 3 (5): 711–717.
https://doi.org/10.1182/bloodadvances.2018028720
Published: 2019
Includes: Supplemental data
Journal Articles

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

Kara L. Davis, Crystal L. Mackall
Journal: Blood Advances
Blood Adv (2016) 1 (3): 265–269.
https://doi.org/10.1182/bloodadvances.2016000034
Published: 2016